Podcasts about Brachytherapy

Send us a textThe Accelerators co-host Dr. Matt Spraker is joined by two experts in brachytherapy for brain tumors, Radiation Onocologist and CMO of GT Medical Technologies Dr. Michael Garcia, MD, MS and Neurosurgeon Dr. Simon Hanft, MD, FAANS.We first review the origin story of GammaTile, an evolution of the practice of brachytherapy for brain tumors. Simon then shares how he has deployed GammaTile in his practice. We dive in to patient selection, how the design facilitates a shallow technical learning curve, and the process of prescribing and placing the implant.Discussion then shifts to research. We review some of the published studies (see links below) that support use of GammaTile for both brain metastases and recurrent primary brain tumors, such as GBM and meningioma. We also discuss some recently completed and soon-to-open trials, including Mike's creative idea - time intensification! -  to move the needle on outcomes for glioblastoma. Here are some of the studies we discussed and other useful links:The ROADS Study The GESTALT StudyEkhator et al., Review of GammaTile Studies Prasad et al., Radiation Protection Considerations for GammaTileGriffin et al., Fast Neutron Therapy for GBMBeckham et al., GammaTile for Salvage of Recurrent Brain Mets and a nice industry summary of findings in context (BioSpace)Dr. Simon Hanft, Building a Successful GammaTile Program (YouTube)A nice Insta patient video by a Dr. Bohnen, a neurosurgeon at Matt's centerEditor's Note: TAP were compensated for this episode and GT Medical Technologies participated in planning the content. The discussions in this episode are the opinions of the participants and are not clinical advice.Please see our website for complete information on our past and current sponsors.The Accelerators Podcast is a Photon Media production. 

In this episode of the ACRO Podcast CURiE Conversations edition, Dr. Jenna Kahn speaks with authors Dr. Scott Silva and med student Caitlin Reichard about their published article, "Dosimetry, Toxicity, and Outcomes of Medically Inoperable Endometrial Cancer Treated With Definitive External Beam Radiation Therapy and Brachytherapy." Contemporary Updates: Radiotherapy Innovation & Evidence (CURiE) is the official publication platform of the American College of Radiation Oncology through the Cureus Journal of Medical Science. Read the full article here: https://www.cureus.com/articles/366834-dosimetry-toxicity-and-outcomes-of-medically-inoperable-endometrial-cancer-treated-with-definitive-external-beam-radiation-therapy-and-brachytherapy#!/

Guest: Ann Klopp, M.D., Ph.D. The recent NRG0238 trial evaluated whether adding chemotherapy to radiation improves outcomes in patients with localized endometrial cancer recurrences. Hear from Dr. Ann Klopp as she explains the findings and how they could shift practice patterns for patient care. Dr. Klopp is a Professor of Radiation Oncology, the Director of Brachytherapy, and the leader of the gynecologic section in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center in Houston.

Guest: Ann Klopp, M.D., Ph.D. Endometrial cancer treatment is continuing to evolve, with surgery guiding initial decisions and new evidence showing that adding immunotherapy significantly improves outcomes in advanced disease. But key questions remain around tailoring regimens to individual patients. Dr. Ann Klopp highlights the latest advances and challenges in management, particularly in patients with pelvic recurrences. Dr. Klopp is a Professor of Radiation Oncology, the Director of Brachytherapy, and the leader of the gynecologic section at the University of Texas MD Anderson Cancer Center in Houston.

Radiation oncologist Dr. Julian Hong explains how radiation therapy works and its central role in treating prostate cancer, both when the disease is localized and when it has spread to limited areas. He outlines major radiation options, including external beam radiation, stereotactic body radiation therapy (SBRT), and brachytherapy, and describes how treatment plans are carefully tailored using imaging, planning scans, and computer modeling to maximize precision and minimize side effects. Hong highlights advances in targeting and beam modulation, which allow for safer, more effective treatment. He also discusses typical timelines for treatment, short- and long-term side effects, and the importance of ongoing follow-up to manage late effects of therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40803]

Radiation oncologist Dr. Julian Hong explains how radiation therapy works and its central role in treating prostate cancer, both when the disease is localized and when it has spread to limited areas. He outlines major radiation options, including external beam radiation, stereotactic body radiation therapy (SBRT), and brachytherapy, and describes how treatment plans are carefully tailored using imaging, planning scans, and computer modeling to maximize precision and minimize side effects. Hong highlights advances in targeting and beam modulation, which allow for safer, more effective treatment. He also discusses typical timelines for treatment, short- and long-term side effects, and the importance of ongoing follow-up to manage late effects of therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40803]

Radiation oncologist Dr. Julian Hong explains how radiation therapy works and its central role in treating prostate cancer, both when the disease is localized and when it has spread to limited areas. He outlines major radiation options, including external beam radiation, stereotactic body radiation therapy (SBRT), and brachytherapy, and describes how treatment plans are carefully tailored using imaging, planning scans, and computer modeling to maximize precision and minimize side effects. Hong highlights advances in targeting and beam modulation, which allow for safer, more effective treatment. He also discusses typical timelines for treatment, short- and long-term side effects, and the importance of ongoing follow-up to manage late effects of therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40803]

Radiation oncologist Dr. Julian Hong explains how radiation therapy works and its central role in treating prostate cancer, both when the disease is localized and when it has spread to limited areas. He outlines major radiation options, including external beam radiation, stereotactic body radiation therapy (SBRT), and brachytherapy, and describes how treatment plans are carefully tailored using imaging, planning scans, and computer modeling to maximize precision and minimize side effects. Hong highlights advances in targeting and beam modulation, which allow for safer, more effective treatment. He also discusses typical timelines for treatment, short- and long-term side effects, and the importance of ongoing follow-up to manage late effects of therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40803]

Radiation oncologist Dr. Julian Hong explains how radiation therapy works and its central role in treating prostate cancer, both when the disease is localized and when it has spread to limited areas. He outlines major radiation options, including external beam radiation, stereotactic body radiation therapy (SBRT), and brachytherapy, and describes how treatment plans are carefully tailored using imaging, planning scans, and computer modeling to maximize precision and minimize side effects. Hong highlights advances in targeting and beam modulation, which allow for safer, more effective treatment. He also discusses typical timelines for treatment, short- and long-term side effects, and the importance of ongoing follow-up to manage late effects of therapy. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40803]

Title: Controversies in Neurosurgery: Brachytherapy in Cranial Oncology: Roles and Limits Guest Faculty: Wenya Linda Bi and Phillip Devlin Hosts: W. Christopher Newman and Seth Oliveria Intracranial brachytherapy has become an increasingly prominent part of the neurosurgical oncologist's toolbox. In this episode, we will explore some of the indications, active areas of exploration, and current controversies surrounding its use.

Routine checkups aren't supposed to flip your world upside down. But for Korrie Medina, they did. In this episode, Lyndsay Soprano sits down with Korrie to talk about what it means to keep living your life while battling cancer.Korrie opens up about the shock of her diagnosis, the rollercoaster of treatments—chemo, radiation, brachytherapy—and the way cancer doesn't just touch your body, but everything: your mind, your relationships, your career. Lyndsay shares her own story too—what it's like to go through the medical system, the emotional fallout, and how women are so often expected to just keep going no matter how brutal it gets.They talk about the messiness of it all—how cancer can change your life in a heartbeat, how asking for help feels like a risk, and how it's easy to lose yourself in the chaos. But they also talk about strength: how to hold on to joy, to find moments of light, and to keep moving forward even when you're running on fumes.This episode is real, raw, and a reminder that no matter what you're going through, you're allowed to take up space and put yourself first.Find Korrie Medina Online Here:Instagram: @korrieanneFacebook: Korrie MedinaFind The Pain Game Podcast Online Here:Website: thepaingamepodcast.comInstagram: @thepaingamepodcastFacebook: The Pain Game PodcastLinkedIn: Lyndsay SopranoYouTube: The Pain Game PodcastEpisode Highlights:(00:00) Introduction to Chronic Pain and Trauma(03:19) Cervical Cancer Diagnosis Journey(04:07) Understanding Cancer Staging and Treatment Options(10:08) The Hybrid Approach to Healing(12:33) Chemotherapy Experience and Its Effects(18:12) Emergency Surgery and Its Complications(23:27) The Importance of Mindset in Healing(25:19) Embracing Happiness Amidst Struggles(26:18) The Mind-Body-Soul Connection(27:39) Navigating the Aftermath of Treatment(28:38) Understanding Brachytherapy(30:36) The Brutality of Medical Procedures(31:32) The Aftereffects of Radiation(33:45) The Reality of Menopause(35:45) Hormonal Imbalance and Mental Health(37:40) Reaching a Breaking Point(39:09) Seeking Help in Crisis(41:31) Reflections from the Psych Ward(43:40) The Importance of Self-Care(45:49) Empowering Women Through Adversity

On this episode host Jonathan Chance speaks with Michael L. Krachon, President of Theragenics about a lesser-known prostate cancer treatment option, brachytherapy.  During the podcast Jonathan and Michael talk about:·       What is brachytherapy and how is it different from other prostate cancer treatments.·       The history of brachytherapy.·       Why brachytherapy is not offered my many doctors?·       An important finding about brachytherapy.·       The importance of doing research on the treatment options for prostate cancer.For more information about Theragenics brachytherapy seeds for prostate cancer visit their website at: https://www.theragenics.com/Prostate Cancer Aware is a copyrighted production. No content maybe rebroadcast or reproduced without the expressed written consent of the Friedman Sidrow Foundation. For more information about prostate cancer, the PSA test, men's health and Jonathan's inspiring new book Unaware, which is about his battle with prostate cancer. Visit our website at: https://www.iknowmypsa.org Email us at: https://www.iknowmypsa.org/contactus/ Follow Prostate Cancer Aware on social media at: Facebook - https://www.facebook.com/iknowmypsa Twitter - https://twitter.com/iknowmypsa or @iknowmypsa Thank you for listening! Remember, Stay Aware and Stay Healthy.™

We are delighted to partner with Western Radiation Oncology today, with two of their distinguished radiation oncologists joining us on the Prostate Health Podcast.  LDR (Low Dose Rate) prostate brachytherapy has recently been an underutilized treatment for prostate cancer. However, advancements in modern techniques have demonstrated that LDR brachytherapy, a procedure that can be performed quite easily in an ambulatory surgery center, offers high cure rates with minimal long-term complications, making it a convenient, non-invasive option for men with prostate cancer. Today, we chat with Dr. Steven Kurtzman and Dr. Ankit Agarwal, two distinguished radiation oncologists working to expand access to LDR brachytherapy by partnering with urologists to establish new programs across the United States.  Drs. Kurtzman and Agarwal are national leaders in targeted real-time intraoperative planned brachytherapy. With over 7,000 implants performed in the past two decades and more than 700 procedures conducted annually, they have managed to preserve this specialized technique despite its limited expansion in recent years. Based primarily in the Bay Area, California, they provide exceptional cancer care while collaborating with urologists, medical oncologists, and prostate cancer specialists across the United States to assist in establishing LDR programs in ambulatory surgery centers nationwide to provide high-quality prostate cancer care. Tune in to learn more about this promising treatment option! Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show Highlights: Who are the most viable candidates for LDR brachytherapy? How the treatments for low, intermediate, and high-risk prostate cancer patients differ The benefits of a combination of brachytherapy and external beam radiation for high-risk prostate cancer patients How factors like urinary function, bowel function, and prostate size can influence men's eligibility for LDR brachytherapy Why prostate size is no longer a limitation for brachytherapy treatment How is the LDR brachytherapy procedure performed? What can patients expect in terms of recovery and side effects following brachytherapy? Post-therapy safety precautions Links:  Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  Get your free What To Expect Guide (or find the link on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Go to the Prostate Health Academy to sign up.  You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. Sponsor Links:  Western Radiation Oncology Brachytherapy for Prostate Cancer with Dr. Steven Kurtzman and Dr. Ankit Agarwal on YouTube Expanding Treatment Options at Ambulatory Surgical Centers: LDR Brachytherapy for Prostate Cancer    

Radiation therapy plays a big role as a curative treatment option for prostate cancer External Beam Radiation Therapy (EBRT) and Brachytherapy are the two primary types of radiation therapy used to treat prostate cancer Surgical isn’t the only option, radiation therapy can also cure some prostate cancers Advantages of radiation therapy – outpatient procedure, doesn’t involve anaesthetics, less potential side effects etc Healthcare professionals play a crucial role in the early stages of prostate cancer diagnosis. They are encouraged to discuss radiation therapy as a treatment option and refer patients to a radiation oncologist for further evaluation and treatment planning Host: Dr David Lim | Total Time: 42 mins Experts: Prof Sandra Turner, Staff Specialist Radiation Oncologist and A/Prof Lucinda Morris, Radiation Oncologist Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEDT Click here to register for the next oneSee omnystudio.com/listener for privacy information.

In this in-depth expose, veterinary oncology technician specialist Jenny Fisher joins Molly Jacobson to explain the ins and outs of radiation therapy for dogs with cancer. Whether you're fearful as you consider radiation for your dog or just curious about how it works, this episode provides invaluable insights.  Topics Covered:  How radiation therapy works and the two types: diagnostic vs. therapeutic  The difference between teletherapy and brachytherapy  What to expect during radiation treatments, including anesthesia use  Short-term and long-term side effects of radiation therapy  When radiation therapy is recommended for dogs with cancer  How stereotactic radiosurgery like CyberKnife offers precision treatment  Tips for preparing your dog for radiation therapy and managing side effects  Your Voice Matters!   If you have a question for our team, or if you want to share your own hopeful dog cancer story, we want to hear from you! Go to https://www.dogcancer.com/ask to submit your question or story, or call our Listener Line at +1 808-868-3200 to leave a question.   Related Videos:  Radiation for a dog with TCC: https://www.youtube.com/watch?v=ZGoyn-1TBsA  What a veterinary technician does: https://www.youtube.com/watch?v=9m7pjiHLhGA   Related Links:  An overview of radiation therapy for dogs: https://www.dogcancer.com/articles/diagnosis-and-medical-procedures/radiation-for-dogs/  An in-depth article on stereotactic radiation: https://www.dogcancer.com/articles/diagnosis-and-medical-procedures/stereotactic-radiation-therapy-for-dogs/   Chapters:  00:00 Introduction  0:15 What Is Radiation Therapy for Dogs?  01:00 Types of Radiation: Teletherapy vs. Brachytherapy  02:45 Common Misconceptions About Radiation Safety  04:00 How Teletherapy Works for Dogs  06:30 The Role of Anesthesia in Radiation Therapy  08:45 How Radiation Targets Tumors  10:30 Curative vs. Palliative Radiation Intent  12:15 Stereotactic Radiosurgery Explained  14:00 Managing Side Effects: Short-Term and Long-Term Effects  18:00 Radiation-Induced Tumors: Risks and Realities  20:30 Preparing Your Dog for Radiation Therapy  23:00 How Technicians Create a Healing Environment  25:15 Tips for Dog Owners: What to Ask Your Vet  27:00 Closing Thoughts: Changing Perceptions Around Radiation    Get to know Jenny Fisher: https://www.dogcancer.com/people/jenny-cassibry-fisher-rvt-vts-oncology/  For more details, articles, podcast episodes, and quality education, go to the episode page: https://www.dogcancer.com/podcast/   Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode of the ACRO Podcast is sponsored by GT Medical Technologies: In the latest episode of the ACRO Podcast, our host ACRO President-elect Brian Lally, MD speaks with Tugce Kutuk, MD, a radiation oncology resident at Ohio State University about GammaTile® Brachytherapy. GammaTile® is surgically targeted radiation therapy that has been FDA-cleared for treating brain tumors.  ACRO podcasts are available on Spotify, Apple, and YouTube.

In this episode, we step into a historical hornet's nest, examining the controversial legacy of nasopharyngeal radium treatments once used for ear infections and adenoid issues in children. We unravel the convoluted data on radiation and cancer risks, hypothesizing about the academic intrigue behind a much-cited 2001 Hopkins study. Most importantly, we question how narratives - especially "radiation equals danger" narratives - shape research and publication. Join us for a thought-provoking dive into the world of radiation medicine, statistical hijinks, and the pressures of scientific storytelling. *** OOTB, produced by Photon Media, is made possible by Cold Light Legacy, a 501(c)(3) nonprofit that thrives on community support. jason@becktamd.com --- Support this podcast: https://podcasters.spotify.com/pod/show/radmed/support

On this episode host Jonathan Chance talks with the esteemed Dr. Andrew Farach who is the Director of Brachytherapy at Houston Methodist Hospital. On this episode during Prostate Cancer Awareness month, Jonathan and Dr. Farach talk about:·       The importance of early detection and getting a PSA test for prostate cancer. ·       Prostate cancer treatment options like Brachytherapy.·       The 310-Program to train more doctors in Brachytherapy treatment.·       Choosing the right doctor after a prostate cancer diagnosis.·       Making informed decisions after a prostate cancer diagnosis.Prostate Cancer Aware is a copyrighted production. No content maybe rebroadcast or reproduced without the expressed written consent of the Friedman Sidrow Foundation. For more information about prostate cancer, the PSA test, men's health and Jonathan's inspiring new book Unaware, which is about his battle with prostate cancer. Visit our website at: https://www.iknowmypsa.org Email us at: https://www.iknowmypsa.org/contactus/ Follow Prostate Cancer Aware on social media at: Facebook - https://www.facebook.com/iknowmypsa Twitter - https://twitter.com/iknowmypsa or @iknowmypsa Thank you for listening! Remember, Stay Aware and Stay Healthy.™

A website for the Prostate Cancer Institute of America:   www.prostatecancerusa.comDr, Ajay Bhatnagar: (33) Ajay Bhatnagar MD,MBA | LinkedIn A recent publication from our guest, Dr. Bhatnagar:Modern Low Dose Rate Brachytherapy For Prostate Cancer: A Comprehensive Guide for Urologists: Bhatnagar, Dr. Ajay, Koneru, Dr. Bobby N., Agarwal, Dr. Manuj, Wallner, Dr. Kent, Patel, Dr. Pratik: 9798338512012: Amazon.com: Books

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Mary McCormack to discuss the INTERLACE trial. Dr. McCormack is an Honorary Consultant Clinical Oncologist at University College London Hospitals NHS Trust and an Honorary Associate Clinical Professor at University College London.   Highlights: • INTERLACE first randomised PH3 trial in Locally advanced cervical cancer in more than 2 decades to demonstrate a clinically meaningful and statistically significant improvement in both OS and PFS . • The IC drugs are widely available and relatively cheap so removing many potential economic barriers to adoption. • Growth factors -GCSF/Filgrastim should be used as needed to ensure patients complete the chemotherapy (IC & cisplatin) • Essential to BEGIN the external beam radiation within 7 days of last dose ( #6) of IC. • Remember OVERALL treatment time for the RADIATION- 96% in trial completed both EXTERNAL BEAM & BRACHYTHERAPY within 56 days.

 In this episode, we're joined by Eve McDavid and Dr. Onyinye Balogun, founders of Mission Driven Tech, a Cervical Cancer innovation company. Their story is an inspirational application of Breaking the Code's themes of inclusive design, varied expressions of pain, and uncomfortable conversations that save lives. Our discussion delves into women's health and cervical cancer, highlighting their current focus: their treatment tool called The Blossom, a medical device used in Brachytherapy, internal radiation procedures that cure Cervical Cancer. The Blossom is designed to alleviate the severe pain and trauma women endure during current brachytherapy procedures, pain so intense it sometimes leads patients to abandon treatment, a devastating and fatal decision.  Mission Driven Tech is raising capital to advance their groundbreaking work, and you can support them by contributing to their crowdfunding campaign featured on their website (https://missiondriventech.com/). Sharing this episode and the links below within your network can also help spread their important message and support their mission to save lives by modernizing cervical cancer treatments.  Special thanks to Jose Walewski for connecting us with Mission Driven Tech!  To contribute to Mission Driven Tech:  https://www.ifundwomen.com/projects/blossom-modern-cure-cervical-cancer Follow Mission Driven Tech on LinkedIn:  https://www.linkedin.com/company/mission-driven-tech Connect with Eve McDavid: https://www.linkedin.com/in/evemcdavid/ Connect with Dr. Onyinye Balogun: https://www.linkedin.com/in/odbalogun/  If you have any questions, feedback, or just want to say hi, email us at medicalanthropology@havas.comCheck out Breaking the Code on LinkedIn: https://www.linkedin.com/company/breaking-the-code-havas-health-and-you-podcast

Editor-in-Chief Sue Yom hosts a British-American conversation about brachytherapy. Guests include Dr. Mahbuba Choudhury, Clinical Oncology Registrar and Stereotactic Radiotherapy Fellow at Imperial College London NHS Trust, and Dr. Imtiaz Ahmed, Consultant Clinical Oncologist and Clinical Lead at Southend University Hospital in the UK, first and supervising authors on this month’s paper, Timing of High-Dose Rate Brachytherapy with External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate Cancer Patients and Its Effects on Toxicity and Quality of Life: A Randomized Controlled Trial, as well as Dr. Akila Viswanathan, Professor and Chair of the Department of Radiation Oncology at Johns Hopkins University, supervising author of two papers publishing together this month, Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the U.S.: A Surveillance, Epidemiology, and End-Results Study and Updated Trends in Brachytherapy Utilization and Disparities in the United States from 2004 to 2020.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Mary McCormack to discuss the INTERLACE trial. Dr. McCormack is an Honorary Consultant Clinical Oncologist at University College London Hospitals NHS Trust and an Honorary Associate Clinical Professor at University College London.   Highlights: • INTERLACE first randomised PH3 trial in Locally advanced cervical cancer in more than 2 decades to demonstrate a clinically meaningful and statistically significant improvement in both OS and PFS . • The IC drugs are widely available and relatively cheap so removing many potential economic barriers to adoption. • Growth factors -GCSF/Filgrastim should be used as needed to ensure patients complete the chemotherapy (IC & cisplatin) • Essential to BEGIN the external beam radiation within 7 days of last dose ( #6) of IC. • Remember OVERALL treatment time for the RADIATION- 96% in trial completed both EXTERNAL BEAM & BRACHYTHERAPY within 56 days.

Dr Akila Viswanathan speaks with Dr Jesse Aronowitz, Emeritus Historian of the American Brachytherapy Society, about the history of the use of brachytherapy to treat cancer and the contributions of two early pioneers in the field from Johns Hopkins, Howard Kelly and Hugh Hampton Young.

Join A Cure in Sight to interview guest, Heather McMenamin, a patient originally from England, currently living in Houston, TX, and diagnosed with ocular melanoma in 2021. “I went for my annual eye exam 9-22-21, (because of COVID it was actually 18 months since my previous eye exam, normally done every year). I was asymptomatic and more concerned about what new frame I might pick out. The doctor was quite concerned about the large mass in my left eye and said I needed to see a retina specialist STAT. I was able to get an appointment for the next morning at which time the doctor dilated my eyes and very quickly said I needed to see an Ocular Oncologist - he did not give me a diagnosis but at this point I knew it was serious.  I was referred to Dr. Amy Schefler and got an appointment 9-29-21. After hours of testing she diagnosed me with Uveal Melanoma. I had Brachytherapy 11-01-21, plaque was in for 7 days. That was an odd experience to look back on. I just had my 2nd year anniversary and so far no sign of METS, next scan 10-19-23 and I began eye injections last month as I have signs of retinopathy.” If you take anything from Heather's episode, we hope you glean that knowledge is so empowering as a patient, and that the knowledge you share with others to help spread awareness makes such a key difference. You can find Heather on facebook, and also in the Houston area if you head to the Houston 5K coming up on Dec 10th!    Her favorite song referenced in this episode is “Take Me Home Country Roads.”    ANNOUNCEMENTS: 5K SITES ARE OPEN FOR REGISTRATION NEAR YOU! Start your team and bring your community to get involved! Highest record for registrations is 306! Who can top it!? Fundraisers have a record of $30K+ in Palo Alto–who can help beat that!?  December 9, Dallas FTW TX https://runsignup.com/Race/TX/FortWorth/LookinForACureFortWorth December 10, Houston, TX https://runsignup.com/Race/TX/Houston/LookinForACureHouston January 20, 2024 Orlando FL https://runsignup.com/Race/FL/Orlando/LookinForACureTampa January 21, 2024, Miami FL https://runsignup.com/Race/FL/Miami/LookinForACureMiami Head to our site to register for a 5K Lookin' for a Cure near you for the remainder of the year!! www.lookinforacure.org Subscribe to the newsletter to stay in the know Newsletter link Email contact@acureinsight.org for questions regarding any upcoming events! ********* Be sure to follow us on Facebook, Twitter, Linked In, or  Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM! *A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more! Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure. Contribute via  PAYPAL OR VENMO or reach out directly to contact@acureinsight.org   

In this episode, Dr Jamie Coleman is joined by Shayna Showalter, MD, from the University of Virginia School of Medicine, Charlottesville, VA. They discuss Dr Showalter's recent study evaluating precision breast intraoperative radiation therapy (PB-IORT), which uses customized CT-based treatment plans for high-dose-rate (HDR) brachytherapy. Interim results show that PB-IORT has an acceptable breast cancer recurrence rate, minimal side effects, and excellent cosmetic outcomes.   Disclosure Information: Drs Coleman and Showalter have nothing to disclose.   To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.   Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.   #JACSOperativeWord

Neuro-oncologist and palliative care specialist, Dr. Akansksha Sharma, talks about radiation treatment for brain tumors. Radiation oncology includes techniques such as external beam radiation therapy (EBRT) and brachytherapy. External beam radiation therapy involves the use of a machine, such as a linear accelerator, to deliver radiation beams from outside the body to the tumor site. The treatment is carefully planned and delivered over a series of sessions, usually on a daily basis. Brachytherapy, on the other hand, involves the placement of a radiation source directly into or near the tumor, allowing for a higher dose of radiation to be delivered locally while minimizing exposure to surrounding healthy tissues.

This week on BackTable Urology, Dr. Juan Javier-Desloges, a urologic oncologist at UC San Diego, interviews Dr. Neil Taunk, a radiation oncologist leading the Brachytherapy and Procedural Radiation program at the University of Pennsylvania, about his experience with using SpaceOAR rectal spacer for prostate cancer radiotherapy. --- CHECK OUT OUR SPONSOR Boston Scientific SpaceOAR Hydrogel https://www.bostonscientific.com/spaceoar --- SHOW NOTES First, the doctors explore the nuances of rectal spacing and the best candidates for this procedure. They discuss various large-scale trials from different research institutions about the efficacy of rectal spacing in different types of radiation, like proton beam, external beam, and brachytherapy. He also notes the time crunch that comes with using a spacer and highlights the importance of understanding a patient's anatomy before performing the procedure. Additionally, he shares his insight on how extracapsular extension of the tumor can affect the rectal spacing procedure, as well as the potential benefits of rectal spacing for certain patient populations. Dr. Taunk also considers the differences between the two gels (Barrigel and SpaceOAR) available on the market and delves into specific differences between the two products. Lastly, they emphasize the importance of pre-operative counseling for the imperfect management of patients because suboptimal gel placements and complications, such as intravascular injection and pulmonary embolism, are possible. --- RESOURCES SpaceOAR Hydrogel by Boston Scientific https://www.bostonscientific.com/spaceoar

Ever wonder how bodies are handled after a nuclear accident? Radioactive corpses may be more common than you think, with certain cancer treatments leaving patients with radiation in their bodies after death. We're looking into guidelines for handling these situations, and what happens when they're not followed.Resources:"Here's why you shouldn't cremate radioactive dead people" by Beth Mole, ArsTechnica"Radiation Contamination Following Cremation of a Deceased Patient Treated With a Radiopharmaceutical" by Nathan Y. Yu, MD1; William G. Rule, MD1; Terence T. Sio, MD, MS1; et al- Journal of the American Medical Association"A Radioactive Dead Body Contaminated An Arizona Crematorium" by Zahra Hirji, BuzzfeedSafety Information, Lutathera website"Brachytherapy", my.clevelandclinic.orglutetium 177 medication profile, Lexicomp"Radiation Safety Concerns in Brachytherapy", nrc.gov"Richard Leroy McKinley- Specialist 4th Class, United States Army" by Michael Robert Patterson, Arlington National CemeteryUniversity Hospitals of Cleveland resources"Medical Examiners / Coroners: Information for Radiation Emergencies", Radiation Emergency Medical Management, US Department of Health and Human Services"Guidelines for Handling Decedents Contaminated with Radioactive Materials", CDC"SL-1: America's First Nuclear Disaster", Kyle Hill on YouTube

In this episode, you'll hear first of an inspiring journey of resilience and innovation as we sit down with cervical cancer survivor, Eve McDavid. She faced the unimaginable—a cervical cancer diagnosis while 35 weeks pregnant. Hear her journey from patient to CEO and Co-Founder of Mission Driven Tech. Then, Dr. Onyinye Balogun shares how this therapy technique has impacted the treatment of gynecologic cancers and why it is so important as Co-Founder and Chief Medical Officer of Mission Driven Tech to improve it further. You don't want to miss this! From the science behind it to the inspiring stories of survivors, our podcast is your gateway to understanding the life-changing impact of Brachytherapy. Did you connect with this episode? Share your thoughts with us on social media using #CervivorPodcast or by emailing us.   For more Cervivor-related content, check out: Cervivor.org. Follow Cervivor on all social media platforms. If you would like to be interviewed as a potential guest for an upcoming episode or would like to request a speaker or topic for a future podcast episode, email us at info@cervivor.org. --- Support this podcast: https://podcasters.spotify.com/pod/show/cervivor/support

In collaboration with ROESCG, we introduce a new series, Cancer Careers! Today we're talking with Dr. Michael Peacock, a Radiation Oncologist at BC Cancer Centre Vancouver. He takes us through his love for radiation oncology, and his interest in brachytherapy. This episode focuses on Please provide us feedback on the episode! 

CivaTech's website: www.civatechoncology.com Dr. Z's TikTok Video: https://www.tiktok.com/@_doctorz/video/7200205235531451694?is_from_webapp=1&sender_device=pc&web_id=7200039723585619499​ CivaTech's TikTok Channel: https://www.tiktok.com/@civatechoncology CivaTech's Instagram: https://www.instagram.com/civatechoncology/ Jessica's X-ray: https://www.amazon.com/Jessicas-X-Ray-Pat-Zonta/dp/1552975770 Designing Your Life: https://www.amazon.com/Designing-Your-Life-Well-Lived-Joyful/dp/1101875321/ref=sr_1_1?keywords=designing+your+life&qid=1676576676&s=books&sprefix=designing+you%2Cstripbooks%2C83&sr=1-1

Dr. Lane Rosen of Willis Knighton Cancer Center sits down with Nate Fluharty to discuss the HPV virus, cervical cancer, and treatment options as well as prevention methods and Willis Knighton's state of the art Brachytherapy system.

Dr. Lane Rosen of Willis Knighton Cancer Center sits down with Nate Fluharty to discuss the HPV virus, cervical cancer, and treatment options as well as prevention methods and Willis Knighton's state of the art Brachytherapy system.

On this episode host Jonathan Chance talks with Dr. Daniel Petereit who is a Radiation Oncologist in Rapid City South Dakota, who has received national recognition for his expertise in brachytherapy, cancer disparities, and clinical trials.  Dr. Petereit talks about the importance of early detection testing for prostate cancer as well as some of the various treatment options for prostate cancer like Brachytherapy, including how in some cases Brachytherapy can be an alternative to prostate removal surgery and weeks of radiation therapy. Dr. Petereit also provides an update on increasing global access to brachytherapy through the ABS 300 in 10 initiative.For more information about prostate cancer, men's health and Jonathan's new book Unaware, which is about his battle with prostate cancer visit: https://www.iknowmypsa.org Also, you can follow Prostate Cancer Aware on: Facebook - https://www.facebook.com/iknowmypsa  Twitter - https://twitter.com/iknowmypsa

In this episode, we'll talk with a national expert on brachytherapy, Dr. Daniel Petereit from Monument Health. Brachytherapy is a type of internal radiation that uses radiation to destroy cancer cells and shrink tumors. Dr. Petereit will explain how this can specifically help with prostate cancer. Hosted on Acast. See acast.com/privacy for more information.

High-dose rate (HDR) brachytherapy is a newer, accelerated cancer treatment that allows physicians to deliver equivalent doses of radiation in as little as one to four outpatient treatments that last just a few minutes each. Matthew Biagioli, MD, a radiation oncologist at the Brian D. Jellison Cancer Institute at Sarasota Memorial, discusses this treatment and why it's another great option for cancer care.You can also watch the video recording on our YouTube channel here.For more health tips & news you can use from experts you trust, sign up for Sarasota Memorial's monthly digital newsletter, Healthe-Matters.

HERE WE GO! Linda and Michael go into the hospital for Brachytherapy. Michael talks about the importance of emotions and what we all need to do.

On this episode host Jonathan Chance talks with Dr. Peter Rossi, who is a radiation oncologist at the Calaway Young Cancer Center in Glenwood Springs, Colorado. He is also the current President of the American Brachytherapy Society - ABS.  Dr. Rossi talks about the mission of the ABS and their roll in providing prostate cancer patients with information about Brachytherapy.  Dr. Rossi also provides important information about the, PSMA, PET imaging scan that many doctors are now using to detect the presence of prostate cancer cells.  For more information about prostate cancer, men's health and Jonathan's new book Unaware, which is about his battle with prostate cancer visit: https://www.iknowmypsa.org

On this episode host Jonathan Chance talks with Michael Krachon, who is the President of Theragenics Interventional who provides significant information about low-dose rate (LDR) brachytherapy seeds for the treatment of prostate cancer, the different types of seeds and the fellowship program Theragenics offers doctors in order for them to learn how to perform brachytherapy and why this is so important. Mr. Krachon has more than 25 years' experience of progressive growth in sales and marketing in the medical industry, especially with brachytherapy devices and delivery systems for the U.S. and International markets. He is also recognized as a national speaker for brachytherapy and market strategies by the industry. For more information about prostate cancer, men's health and Jonathan's new book Unaware, which is about his battle with prostate cancer visit: https://www.iknowmypsa.org

On this episode host Jonathan Chance talks with Dr. Peter Orio, who is the Vice Chair of Network Operations at the Dana-Farber | Brigham Cancer Center Department of Radiation Oncology.  He is also the Director of Prostate Brachytherapy and an Associate Professor at the Harvard Medical School. Dr. Orio provides important information about the various forms of radiation therapy for the treatment of prostate cancer as well as what questions a patient should ask their doctor about radiation therapy. For more information about prostate cancer, men's health and Jonathan's new book Unaware, which is about his battle with prostate cancer visit: https://www.iknowmypsa.org

Neil Taunk, MD, MSCTS, discusses Penn Medicine's high-dose rate brachytherapy, a new offering from Penn Medicine.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. David Gaffney, Dr. Carien Creutzberg, and Dr. Anuja Jhingran to discuss this month's special issue on radiation oncology. Dr. Gaffney, MD, PhD, Senior Director of Clinical Research, is Professor and Vice-Chair of the University of Utah (U of U) Department of Radiation Oncology. Dr. Gaffney is a distinguished clinician and a long-standing leader in clinical research, and he is also a past president of the American Brachytherapy Society. Dr. Carien Creutzberg is Professor of Radiation Oncology at Leiden University Medical Center, the Netherlands. She specializes in research and treatment of gynecological cancers and has been initiator and principal investigator of the four PORTEC trials and the TransPORTEC consortium. She is current chair of the GCIG Endometrial Cancer Committee and past Council member of ESGO and IGCS. Dr. Anuja Jhingran is a Professor of Radiation Oncology in the Section of Gynecology at The University of Texas MD Anderson Cancer Center. She is the present treasure/secretary for IGCS. She is highly active in GCSC, GCIC, ASCO, and SGO. Her passion is to improve treatment for all women with gynecological cancer throughout the world and she does this through mentoring physicians in underserved regions throughout world. Highlights: Stereotactic body radiation therapy (SBRT) is useful in gynecological cancers. Brachytherapy improves survival in cervix cancer. Image guidance in radiation oncology decreases morbidity. Patients with small volume disease and long disease-free interval may be good candidates for SBRT. Immunotherapy can be combined with radiation therapy.

What is brachytherapy and how are isotopes involved? 5 min Pandemics & Pathogens Past & Present Podcastchemsmith1@gmail.comFacebookTwitter @chemsmithInstagram @timcsmith1961 Direct Link to episode

*Don't forget to register for our first ever annual STEPS FOR SIGHT Challenge! Register yourself and your team at the link below--or donate to the overall goal: https://www.charityfootprints.com/sight/eventdetails A Cure in Sight is joined by Tanya Gibson, sharing her journey since being diagnosed in March 2021 with choroidal melanoma. She summarizes her story below: Tanya Gibson Cancer & Leadership  I remember the moment I knew that I was going to hear “you've got cancer”.  It was the day after my doctor called me to tell me he was “worried”.  Something in me, my inner knowing, took over after that phone call.  I had the best sleep.  I woke up rested and clear headed.  I went to the computer and looked up everything he had told me.  And I knew.  I thought “Fuck.  I'm going to find out I have cancer.”  And just like that it was go time.  I had just been given the opportunity to put into practice everything I had learned over the past 20 years about mindset, leadership, energy, emotional intelligence, health and healing.  I sat down with a piece of paper and wrote “how do I want to experience this journey.”   I needed to be quiet for a while. I kept what I knew to myself, to protect my energy & mindset, until I was strong enough to handle other people's experiences, fears and projections with cancer.  You see, when people love you, their worries and fears can be dominant.  I needed to be rock solid to handle that and not absorb it.  I had to get my body ready for something it had never done before, go through 2 surgeries in a week. Nourishing it and ensuring it was as strong as possible. I was facing a new challenge. One I needed to lead myself through fully empowered, full of optimism and in full physical strength. I had to be unshakeable in holding MY vision of MY future. I needed to be unstoppable. It all started in March 2021, at an annual eye exam, my eye doctor found something suspicious. He called me in the evening to say “I'm worried”. After 4 weeks of appointments, specialists, tests & hospitals, I was told the diagnosis, choroidal melanoma.  I remember phrases as I was focusing on breathing.  How did you end up here?  We've never gotten one this small.   It was caught early.  Excellent prognosis.  Radiation.  Keep your eye.  Risks.  Ocular muscle.  90%.  Sign here.  Pre-op testing today.  I was in a daze still trying to comprehend all that I was told as I was having x-rays and scans and blood tests to prepare for surgeries in 2 weeks.  I left the hospital and walked for an hour processing everything I had been told.  The bottom line was this was caught through an annual routine eye exam, before it had progressed to be symptomatic.  I decided that I was expected to make a full recovery with this being a minor speed bump in life. It was overwhelming. It didn't feel real. It felt scary, AND it was great news. Considering what I had just been told, I was excited because it was the best outcome that was possible. THAT needed to be my focus. At the same time, I was equally exhausted, filled with so many emotions and I needed to cocoon. I wanted processing time.  I needed to figure out how I was going to move through this experience. In April, I had surgery for Brachytherapy, where a radiation plaque was placed on my eye, and another surgery to remove it a week later.  My nephew concluded, in his 7-year old innocence, that I would have a bionic eye with special powers.  I liked that and that is how I now think of it.   The surgeries went better than expected, leaving all muscles and nerves fully intact.  It has been a journey since April, adjusting to life with a “bionic eye”.  I have had challenges through recovery.  I have spasms in my eye and shots of pain.  I struggle with screen time.  I was scared to drive and it has taken me quite a while to adjust to nighttime driving.  My eye is sensitive to the light.  I can wake up with tons of energy and need a nap 2 hours later as I fatigue easily.  I am learning to live life differently with these challenges.  Many people comment on the visual aspect that they see saying things like “you look so good” or “you can barely tell”, but what no one can see is how cancer changes you on the inside.  And that has been the biggest journey of all!     I believe that what we put our attention on grows.  While I have side effects, I don't give them much attention or talk about them much.  No one can truly understand what we each go through.  But that is the same with everything in life.  No two diagnosis are the same, no two divorces are the same, no two parenting experiences are the same.   We are unique and therefore our experiences are unique to us.  I am learning to live with the ways that I am different and work with that.  I acknowledge how I am feeling, I honour the feelings, I give them space and I rest when I need to.  But my main focus is on gratitude.  I would rather put the attention on all of the things that I feel grateful for.  My eyesight is fully intact.  I get to see all the beauty that surrounds me.  The tumour is controlled.  I get to experience more in life as a result.  My body has an incredible ability to heal and it is continuing to get stronger every day!   One of my core beliefs in life is that we get to create the life we desire.  The things that happen to us in life are neither good or bad, but rather it is how we experience it that we end up defining as good or bad.  We choose our response to the circumstances and that informs our experience.   I honour the feelings I have, and I choose to move forward with gratitude and optimism.   Just 3 weeks prior to this diagnosis, I had completed a restructuring at work and was in my final months of my corporate job.  I was ready to pursue a new career challenge with a focus on leadership.  At the same time, the city I lived in, Toronto, Canada, was in a lockdown state due to the pandemic.   The circumstances were less than ideal to receive a cancer diagnosis, but they were just circumstances.      It certainly felt like an overwhelming blow.  It knocked the wind out of me, there were plenty of tears.  But those beliefs I have rang loud and clear.  I get to decide how I will experience this. I create the life I desire.   It is up to me to choose my response to these circumstances.   During the time between diagnosis and prognosis, I sat and journaled on two main themes.  I repeatedly wrote and reflected on one question “What if this were my last summer”.  Once I was able to get through all of the tears and scary “what if” scenarios, I realized that no matter what, whether I had one summer left or sixty summers left, I wanted to experience it with fun, laughter and love.  I wanted to live a valuable life with meaning and purpose.  And that became part of my approach.  The other thing I did was I wrote my obituary.  I wrote it from the perspective of my 106 year old self, looking back on my life.  I concluded that I wanted to be a youthful and energetic old lady at 106, with her beautiful eyes and eyesight intact, filled with love, and a sparkle and twinkle of curiosity and mischief in them.  I wanted to be able to look back on this experience and know that I did something great with it.   Our circumstances don't define us.  It's what we do with the circumstances that is truly defining.  I had to look at this situation from the perspective of how I wanted to feel and what I can learn from this.     With these challenges I was facing, came the opportunity to strengthen my resolve and lead myself in new ways, to better prepare me for the future I desired to create and build and to gain clarity on the impact that I wanted to have.   Ultimately, that is what leadership is.  We are faced with challenges and we step up to figure out how to move through them and sometimes we inspire others along the way.   We go first and pave a path for others to follow and have an easier journey.  We lead by example to show others if we can do it, so can they.  We remain optimistic, believing that no matter what, things will always work out, even during the toughest of times.     While it is important to have a plan in life, it is even more important to realize that things rarely happen how we plan.  When we get hung up on what did or didn't happen, we stay stuck.  Our success comes not from the plan, but how we how we adapt, pivot and respond to the curveballs along the way.   Our growth comes not from the results, but from taking a step back to reflect on the action we took and finding the lessons along the way.  Our progression comes not from what we achieved, but from figuring out how we can raise the standard and do better next time.   I look back on the 2021 that I never imagined, yet feel proud at all I've overcome.  I am incredibly excited to be stepping into each day, with a whole new perspective, a redefined vision with a bionic eye and even more leadership skills & lessons than before. I had a 6 in 1 million chance of getting this. I had never heard of this type of cancer. It's considered rare. My prognosis is incredible, thanks to early detection.  I plan to exceed expectations and do it my way.  I know this will be a story I will tell in my 100's, letting everyone know how rare I am as I look at all of the beauty around me feeling so grateful for an incredible life, my gorgeous eyes and eyesight. Remember, I create the life I desire! ************************ Be sure to follow us on Instagram @acureinsight, for more stories, tips, and ideas to help you navigate this journey with OM!   *A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more! Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure. LINK TO PAYPAL OR VENMO  This podcast was hosted by Danet Peterson and produced by Agora Media.

Dr. Arif Ali is a board-certified radiation oncologist at Peeples Cancer Institute in Dalton, Georgia. For more information about Peeples Cancer Institute, call 844-PCI-HOPE or visit HamiltonHealth.com/cancer. This program in no way seeks to diagnose or treat illness or to replace professional medical care. Please see your healthcare provider if you have a health problem.

Dr. Nelson Stone MD discusses Prostate Brachytherapy 5/8/20

Internal radiation therapy, also known as brachytherapy, continues to be a viable option for treating prostate cancer. Have you ever wondered if you would be the right candidate for that sort of therapy? Or how brachytherapy works in treating prostate cancer?  We are excited to have a special guest with us on the show today! Dr. Ronald Chen is an internationally renowned radiation oncologist and prostate cancer expert, and he is joining us to answer those questions and some other ones and discuss some of the recent advances in brachytherapy. Stay tuned for more! Dr. Chen is currently the Department Chair of Radiation Oncology at the University of Kansas Medical Center. He has helped write many of the national standards and guidelines on the treatment of prostate cancer, and he lectures across the US and internationally on the treatment of prostate cancer. His research interests involve the long-term outcomes of prostate cancer patients and survivors. That includes the effectiveness and long-term quality of life effects of the different treatments for prostate cancer. He completed his residency training at the Harvard Radiation Oncology Program in Boston, and he served on the faculty at the University of North Carolina in Chapel Hill before becoming the Chair of Radiation Oncology at KU in 2019. Be sure to listen in today to find out all you need to know about brachytherapy as a viable treatment option for prostate cancer. Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation.  Show highlights: Dr. Chen explains what brachytherapy is. How brachytherapy works in treating prostate cancer. The benefits of brachytherapy. Dr. Chen explains how the implants are placed technically inside the prostate. Dr. Chen describes how he maps out where the brachytherapy seeds go. Dr. Chen discusses whether or not brachytherapy involves a permanent implant, how long the implant stays in the prostate, and how long the implants remain active inside of someone. Some precautions that men need to take while the seeds are still active inside of them. The difference between low dose rate brachytherapy and high dose rate brachytherapy. Dr. Chen explains who he would and would not consider a viable candidate for brachytherapy. Some of the risks of using brachytherapy to treat prostate cancer.What men should expect from their PSA following brachytherapy.     Some of the future changes or advances that Dr. Chen sees coming down the pipeline for brachytherapy for prostate cancer. Links and resources: Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  Get your free What To Expect Guide (or find the link here, on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Go to the Prostate Health Academy to sign up for the wait-list for our bonus video content.  Dr. Ronald Chen's website

Today, we have Radiation Oncologist, Dr. James Yu, joining us to talk about radiation therapy for prostate cancer. In today's episode of the Prostate Health Podcast, we will be focusing on some of the basics of radiation therapy for prostate cancer, and Dr. Yu will also discuss some of the emerging advances in this area. Stay tuned, for more! Dr. Yu is the Director of Yale Medicine's Prostate and Genitourinary Cancer Radiotherapy Program. His clinical aim includes treating his patients with state-of-the-art, evidence-based care that takes their values and goals into account as well as their medical condition. Dr. Yu also researches ways to use radiotherapy treatments to improve outcomes for cancer patients, including comparing the effectiveness of new radiation technologies, and how these new technologies are adopted nationally. Be sure to tune in today, to hear what Dr. Yu has to share about the basics of radiation therapy for prostate cancer, and to find out about some of the advances that are emerging in that area.  Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show highlights: Dr. Yu explains how radiation therapy works in treating prostate cancer. A review of some of the current basic options for treating prostate cancer with radiation. Dr. Yu goes through the process of radiation therapy for prostate cancer, starting with external beam radiation therapy. He explains what to expect, in terms of pre-radiation planning, the number of treatments that are involved, and some of the various approaches to the beamed-in radiation.     The different types of approaches to radiation, and the number of weeks of treatment they entail for the patient. Dr. Yu outlines some of the potential side-effects of external beam radiation therapy. Dr. James Yu, together with Dr. Judd Moul, who appeared in episode 2, and Dr. Dan Hamstra, wrote an article that was published in Oncology, in 2017, about whether surgery or radiation is the better treatment for quality-of-life purposes. Brachytherapy compared with external beam radiation therapy, as options for the treatment of prostate cancer. Dr. Yu describes the process of implanting the seeds for low-dose brachytherapy. The rationale behind why hormone therapy, or ADT (Androgen Deprivation Therapy), is given in conjunction with radiation treatment, and the length of time that someone would need to be on that treatment. Dr. Yu explains how he counsels patients in terms of monitoring their PSA following therapy, and what they can expect in watching their PSA. What the PSA nadir means, and how a cancer recurrence would be defined after external radiation therapy. Dr. Yu explains that everything in prostate cancer is a conversation with the patient. Some details about salvage radiation therapy after surgery. Some of the advances in radiation treatment for prostate cancer, and what moderate hypofractionation means when compared with the more conventional treatments for prostate cancer. About extreme hypofractionation, or SBRT (Stereotactic Body Radiotherapy), for prostate cancer. Where we are, currently, with proton therapy as a treatment for prostate cancer, and how proton therapy compares with the conventional radiation treatments for prostate cancer. Dr. Yu talks about the Space OAR Hydrogel. He explains how it is administered and how it works in terms of minimizing toxicity. Looking at the notion of treating certain patients with metastasis by treating the prostate, or possibly even sites outside of the prostate, in addition to hormone therapy. Radiation that was delivered ten or twenty years ago is not the same as the radiation that's being delivered today. The ability to spare normal tissue has improved a lot.  Links and resources: Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  To get your free What To Expect Guide, go to www.prostatehealthpodcast.com/clinic    Or find the link on our podcast website - www.prostatehealthpodcast.com